?u= Wed, 06 Nov 2024 01:07:20 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.1 ?u=/wp-content/uploads/2024/11/cropped-icon-150x150.png ?u= 32 32 ?u=/product/publishers/iso/iso-pas-188731999/ Wed, 06 Nov 2024 01:07:20 +0000 International protocol for doping control

Published By	Publication Date	Number of Pages
ISO	1999-12	84

]]> International protocol for doping control

Published By	Publication Date	Number of Pages
ISO	1999-12	84

]]> ?u=/product/publishers/din/din-58989/ Tue, 05 Nov 2024 15:16:15 +0000 Haemostaseology - HPLC-MS methods for the quantification of direct oral anticoagulants (DOAC) - Rivaroxaban

Published By	Publication Date	Number of Pages
DIN	2018-10	24

]]> Rivaroxaban [rINN] is an oral, highly selective direct Factor Xa (FXa) Inhibitor and has an anti-coagulatory effect. This standard describes methods for measuring concentrations of the direct oral anticoagulant (DOAC) rivaroxaban in human plasma samples. This document is applicable to developers and manufacturers of rivaroxaban assays, medical laboratories, as well as institutions and commercial organizations performing biomedical research.

]]> ?u=/product/publishers/din/din-58988/ Tue, 05 Nov 2024 15:16:15 +0000 Haemostaseology - Reference method for the VWF multimeres

Published By	Publication Date	Number of Pages
DIN	2010-03	13

]]> This standard applies to the determination of the number or the size distribution, respectively, of the multimeres of the human von Willebrand factor as well as the assessment of the substructures of the VWF multimeres in citrated plasma or in factor concentrates.

]]> ?u=/product/publishers/din/din-58987/ Tue, 05 Nov 2024 15:16:14 +0000 Haemostaseology - Reference method for the VWF antigen

Published By	Publication Date	Number of Pages
DIN	2010-03	15

]]> The document applies to the immunological determination of the VWF antigen concentration (VWF:Ag) in citratplasmas and factor-concentrations. The ELISA technique and the automated particle-enhanced agglutination are selected as reference methods.

]]> ?u=/product/publishers/din/din-58932-6/ Tue, 05 Nov 2024 15:16:02 +0000 Haematology - Determination of the concentration of blood corpuscles in blood - Part 6: Reference method for the determination of the concentration of CD4 positive lymphocytes (Draft)

Published By	Publication Date	Number of Pages
DIN	2021-02	35

]]> This document applies to the determination of CD4-positive lymphocytes in human blood using a reference method. It only applies to the analytical phase. Working according to the equipment specific and metrological requirements of this document ensures, that the concentration of CD4-positive lymphocytes in blood is determined with a minimal measurement uncertainty. This document applies also for the counting of particles in stabilized control blood with fixed human blood cells or in suspensions with particles of non-biological origin (e. g., micro-particles with surface antigens), if the particles to be measured have a metrological behavior like CD4-positive lymphocytes.

]]> ?u=/product/publishers/din/din-58932-5/ Tue, 05 Nov 2024 15:16:00 +0000 Haematology - Determination of the concentration of blood corpuscles in blood - Part 5: Reference method for the determination of the concentration of thrombocytes

Published By	Publication Date	Number of Pages
DIN	2007-10	37

]]> The aim of the standard is to specify a reference method for the determination of thrombocytes in human blood.

]]> ?u=/product/publishers/din/din-58932-3/ Tue, 05 Nov 2024 15:15:59 +0000 Haematology - Determination of the concentration of blood corpuscles in blood - Part 3: Reference method for the determination of the concentration of erythrozytes

Published By	Publication Date	Number of Pages
DIN	2017-01	64

]]> This standard applies to the determination of the concentration of erythrocytes in human blood by a reference method. It is applicable to the analytical phase only. When applying the reference procedure specified in this standard the technical and metrological requirements ensure that reference values for the concentration of erythrocytes in blood are determined with an inaccuracy as small as possible. This standard also applies to corpuscle counting in stabilised control bloods containing fixed human blood corpuscles or particles of non-biological origin, e. g. beads labelled with surface antigens, if the metrological behaviour of the corpuscles to be measured corresponds to that of erythrocytes as defined in the standard (3.3).

]]> ?u=/product/publishers/din/din-58932-1/ Tue, 05 Nov 2024 15:15:58 +0000 Hämatologie - Bestimmung der Blutkörperchenkonzentration im Blut - Teil 1: Blutentnahme, Probenvorbereitung, Einflussgrößen, Störfaktoren

Published By	Publication Date	Number of Pages
DIN	2012-04	10

]]> Das Dokument gilt für die Blutentnahme zur Bestimmung der Blutkörperchenkonzentration im Humanblut, das durch Zusatz von Antikoagulantien oder durch hohe Verdünnung mit einer isotonen wäßrigen Lösung ungerinnbar gemacht wurde.*Inhaltsverzeichnis

]]> ?u=/product/publishers/din/din-58924/ Tue, 05 Nov 2024 15:15:57 +0000 Hämostaseologie - Referenzmethode zur Bestimmung der Collagenbindungsaktivität des VWF

Published By	Publication Date	Number of Pages
DIN	2022-05	20

]]> Dieses Dokument ist anwendbar für die Bestimmung der funktionellen Collagenbindungsaktivität des humanen Von Willebrand Faktors in Citratplasma und von gereinigtem plasmatischen oder rekombinanten Von Willebrand Faktor in pharmazeutischen Präparaten.

]]> ?u=/product/publishers/din/din-58931/ Tue, 05 Nov 2024 15:15:57 +0000 Hämatologie - Bestimmung der Hämoglobinkonzentration im Blut - Referenzmethode (Entwurf)

Published By	Publication Date	Number of Pages
DIN	2021-02	48

]]> Dieses Dokument gilt für die Bestimmung der Hämoglobinkonzentration im Blut. Sie gilt nur für die analytische Phase. Sie legt Anforderungen an die Geräte- und Messtechnik sowie an die benötigten Reagenzien bzw. deren Lösungen, die bei der Bestimmung der Hämoglobinkonzentration im Blut eingesetzt werden, fest. Dieses Dokument gilt auch für die Hämoglobinbestimmung in Kontrollmaterialien, wenn sich Lyse und Umwandlungsgeschwindigkeiten der verschiedenen Hb-Varianten ähnlich wie im Frischblut verhalten.

]]>